Regulation of the stability of ␤ catenin protein is a critical role of Wnt signaling cascades. In early Xenopus development, dorsal axis specification depends on regulation of ␤ catenin by both cytoplasmic and nuclear mechanisms. While the cytoplasmic protein axin is known as a key component of the cytoplasmic ␤ catenin degradation complex, loss-of-function studies are needed to establish whether it is required for dorso-ventral patterning in the embryo, and to test where in the embryo it carries out its function. Here, we show that embryos lacking maternal axin protein have increased levels of soluble ␤ catenin protein and increased nuclear localization of ␤ catenin in ventral nuclei at the blastula stage. These embryos gastrulate abnormally and develop with excessive notochord and head structures, and reduced tail and ventral components. They show increased expression of dorsal markers, including siamois, Xnr3, chordin, gsc, Xhex, and Otx2, decreased expression of Xwnt 8 and Xbra, and little alteration of BMP4 and Xvent1 and -2 mRNA levels. The ventral halves of axin-depleted embryos at the gastrula stage have dramatically increased levels of chordin expression, and severely decreased levels of Xwnt 8 mRNA expression, while BMP4 transcript levels are only slightly reduced. This dorso-anterior phenotype is rescued by axin mRNA injected into the vegetal pole of axin-depleted oocytes before fertilization. Interestingly, the phenotype was rescued by ventral but not dorsal injection of axin mRNA, at the 4-cell stage, although dorsal injection into wild-type embryos does cause ventralization. These results show directly that the localized ventral activity of maternal axin is critical for the correct patterning of the early Xenopus embryo.
INTRODUCTION
Patterning of the early Xenopus embryo is accomplished by the localized activity of maternal transcription factors, initiating transcriptional cascades, and specific signaling pathways (Heasman 1997; Fraser and Harland, 2000; Xanthos et al., 2001) . Wnt signaling pathways have multiple roles to play in this process. Most attention has focussed on the involvement of Wnts in dorsal specification, since early studies showed that Wnt 8, 8b, and 11 have the ability to induce dorsal axial structures (reviewed in Heasman, 1997; Moon and Kimelman, 1998) . Although the initiating signal remains to be identified, many components of the Wnt cascade have since been described (reviewed in Sokol, 1999) . The critical effect of the cascade is the stabilization of ␤ catenin, which enhances its interaction with the maternal DNA binding protein XTcf3 and results in the regulation of zygotic dorsal target genes (Carnac et al., 1996; McKendry et al., 1997; Molenaar et al., 1996; Brannon et al., 1997; Barker et al., 2000) In addition to this early role, Wnt pathway components may also be required for generating Ca 2ϩ waves (Kuhl et al., 2000b) , gastrulation movements (Wallingford et al., 2000) promoting ventral fates (Itoh and Sokol, 1999; Kuhl et al., 2000a) , and head patterning (Itoh et al., 1995; Heasman et al., 2000) . Understanding the regulation of these events is critical to understanding the patterning of the early embryo.
The mechanisms regulating Wnt cascades are complex. One key point of intracellular control is at the level of ␤ catenin, which may undergo both cytoplasmic and nuclear regulation. In the cytoplasm, a multiprotein complex inter-acts with ␤ catenin causing its phosphorylation and degradation. This complex includes the protein axin, first described as the product of the fused locus in the mouse (Zeng et al., 1997) . The Drosophila homolog, D axin, has been shown to negatively regulate Wingless signaling (Hamada et al., 1999 : Willert et al., 1999 . In Xenopus, both axin and a second axin-related protein (Xarp) have been identified (Hedgepeth et al., 1999a; Itoh et al., 2000) . Axin acts as a scaffold which interacts with many proteins, including GSK3, PP2A, APC, and the signal transduction component, dishevelled (for review, see Sokol, 1999) . Axin and GSK3 have been shown to be required for ␤ catenin degradation (Hart et al., 1998; Ikeda et al., 1998; Yamamoto et al., 1998; Salic et al., 2000) . The GSK-binding protein, GBP, has also been identified as an essential inhibitor of GSK function (Yost et al., 1998) . In the currently accepted model, Wnt signaling activates dishevelled, thus causing the stabilization of ␤ catenin, by preventing its binding to and/or phosphorylation by this complex on the dorsal side of the early embryo. The evidence that axin negatively regulates dorsal axis specification is based on studies that show that dorsal overexpression of the wild-type mouse Axin protein in the early embryo causes a ventralized phenotype (presumably by binding and degrading more ␤ catenin) (Zeng et al., 1997) . The accepted definition of a ventralized state is a headless, dorsal axis deficient phenotype that lacks the expression of dorsal markers such as siamois, Xnr3, and chordin. Over-expression of a dominant negative form of the protein causes axis duplication, either by blocking ␤ catenin association with wild-type axin (Zeng et al., 1997; Fagotto et al., 1999; Salic et al., 2000) , or by inhibiting GSK-3 activity (Hedgepeth et al., 1999b) .
In the nucleus, several possible regulators of ␤ catenin have been identified. The nuclear protein duplin (Sakamoto et al., 2000) and the HMG box protein Xsox17 (Zorn et al., 1999) suppress axis formation, while the cyclic AMP response element binding protein CBP acts as a positive regulator (Hecht et al., 2000; Takemaru and Moon, 2000) . It is likely therefore that several mechanisms operate at once to regulate ␤ catenin signaling, although the relative importance of these components in the early embryo is unknown.
A central question in understanding the establishment of dorsal/anterior and ventral/posterior pattern in the embryo is, what are the relative roles of the dorsal and ventral signaling pathways? The early models proposed ventral as being the ground or "default" state for mesoderm (Smith, 1989; Sive 1993) . More recently, it has become clear that BMP-signaling originating outside the organizer induces ventral mesoderm (Graff et al., 1994; Schmidt et al., 1995) , using Smad1 as a signal transducer (Graff et al., 1996) . The degree to which dorsal and ventral fates in the embryo are independently specified remains to be understood.
To test whether axin is required for dorsal axis specification, and when and where it is required, we carried out loss-of-function studies. We depleted maternal axin mRNA and protein from Xenopus oocytes using antisense oligonucleotides and studied the effect on embryonic development. We found that the maternally stored pool of axin mRNA is essential for normal development. When the levels of protein in the early embryo were reduced only slightly, the amount of endogenous soluble ␤ catenin protein was increased, and there was increased nuclear localization of ␤ catenin in ventral nuclei. Embryos developed normally until gastrulation but then gastrulated abnormally and developed with excessive notochord and head structures, and reduced tail and ventral components. They had the classical "dorsal" phenotype first described as the result of lithium treatment. Embryos depleted of maternally encoded axin protein (mat-axin Ϫ embryos) showed increased expression of dorsal markers, including siamois, Xnr3, chordin, gsc, Xhex, and Otx2 , decreased expression of general and ventral mesodermal markers, Xwnt 8 and Xbra, and surprisingly little alteration of BMP4 and Xvent1 and -2 mRNA levels. To determine whether these effects were localized dorsally or ventrally, wild-type and mat-axin Ϫ gastrulae were bisected.The ventral halves of axin-depleted embryos were shown to have dramatically increased levels of chordin expression, and severely decreased levels of Xwnt 8 mRNA expression, while BMP4 transcript levels were only slightly reduced. This shows that, while Xwnt 8 expression is negatively regulated by the maternal ␤ catenin-XTcf3 pathway at the midgastrula stage, BMP4 expression is not.
To confirm that this phenotype was specifically due to the loss of axin, we carried out rescue experiments. The dorsal-anterior phenotype was rescued by axin mRNA injected into the vegetal pole of axin-depleted oocytes before fertilization. Since axin mRNA injected into the dorsal side of wild-type embryos routinely caused ventralization (Zeng et al., 1997; Fagotto et al., 1999) , we predicted that injection of axin mRNA into either the dorsal or ventral sides of axin-depleted embryos should rescue the phenotype. We found that the phenotype was rescued by ventral but not dorsal injection of axin mRNA, although dorsal injection into wild-type embryos does cause ventralization. These results are discussed with regard to current models of axis formation.
MATERIALS AND METHODS

Oocytes and Embryos
Oocytes were manually defolliculated and cultured as described in Kofron et al. (1999) . Oocytes were injected with oligos and mRNA in oocyte culture medium (OCM) as described in the text, cultured at 18 degrees, and fertilized using the host transfer technique as described in Zuck et al. (1998) . Rescue experiments were carried out as described in the text. Eggs were stripped and fertilized by using a sperm suspension and embryos were maintained in 0.1ϫ MMR. For injections of mRNA after fertilization, embryos were dejellied, and transferred to 2% Ficoll in 0.5ϫ MMR at the 1-cell stage. mRNAs were diluted with sterile distilled water and injected into blastomeres.The dorso-ventral axis was recognized at the 4-cell stage, by the pigmentation differences of the dorsal and ventral sides, which occurred normally in mat-axin Ϫ embryos. Only those embryos with obvious dorso-ventral differences and regular cleavage planes were selected for injection. Embryos were washed thoroughly and returned to 0.1ϫ MMR during the blastula stage. For dissections at the gastrula stage, embryos were placed on 2% agar dishes in 1ϫ MMR and bisected into dorsal and ventral halves, using the site of the dorsal lip as a guide to the dorsal side.
Oligos and mRNAs
The antisense oligodeoxynucleotides used were HPLCpurified phosphorothioate-phosphodiester chimeric oligonucleotides (Sigma/Genosys) with the base composition: M7, 5Ј-T*T*C*C*TCGCCAGGAA*C*T*G*G; M5, 5Ј-C*C*T*AGG-TGCATCTTC*A*G*T, where * represents a phosphorothioate bond. Oligos were resuspended in sterile, filtered water and injected in doses of 2-4 ng per embryo. Since oligo 7 was most effective in degrading axin mRNA (Fig. 1) , it was used in most experiments. Capped axin mRNA was synthesized by using the mMessage mMachine kit (Ambion) from pCS2 ϩ vector, linearized with NotI, and transcribed by SP6, ethanol precipitated, and resuspended in sterile distilled water for injection. Axin mRNA was tested for its ability to make protein by injecting it into wild-type embryos in a range of doses as described in Results. Embryos were analyzed both by Western blotting using the Xenopus axin antibody at the midblastula stage, and for ventralized phenotype at the tailbud stage.
Northern Blot Analysis
Embryo RNA was extracted as described (Gurdon et al., 1985) . Electrophoresis and Northern blotting were performed as described (Hopwood et al., 1989) using two embryo equivalents per lane. The axin probe was synthesized by random priming of the excised insert of an NCO1 digest of PCS2 ϩ axin. Blots were stripped and rehybridized with a probe for plakoglobin mRNA (EcoRI-Xba fragment) as a loading control, and with a probe for the related molecule Xarp (332-bp Xba fragment) prepared in the same way.
Analysis of Gene Expression Using Real Time RT-PCR
Total RNA was prepared from oocytes and embryos by using the proteinase K method and treated with RNase-free DNase 1 (10 g/l Boehringer Mannheim) prior to cDNA synthesis. cDNA was synthesized from 0.5 to 1.0 g RNA by one of two methods. Method 1 utilized random hexamers to prime cDNA sythesis as described (Zhang et al., 1998) in a volume of 20 l. After reverse transcription, 30 l H 2 O, 1 l glycogen (20 g/l), and 10 l 5 M ammonium acetate were added to each RT reaction. Each sample was extracted once with phenol/chloroform/isoamyl alcohol (25: 24:1) and precipitated overnight at Ϫ20°C with 2.5 vol 100% EtOH. Samples were centrifuged at 4°C, 16,000g for 15 min, washed with 70% EtOH, dried in a speedvac, and resuspended in 150 l H 2 O per 1/6th embryo equivalent of RNA used for cDNA synthesis. Method 2 utilized oligo(dT) priming under the same reaction conditions. After synthesis, the cDNA was diluted to a final volume of 150 l and used directly for RT-PCR.
RT-PCR was carried out by using a LightCycler System (Roche), which allows amplification and detection (by fluorescence) in the same tube, using a kinetic approach. LightCycler PCRs were set up in microcapillary tubes using 5 l cDNA with 5 l of a 2ϫ SYBR Green I (Roche Molecular Biochemicals) (Wittwer et al., 1997) master mix containing upstream and downstream PCR primers, MgCl 2 , and SYBR Green. The final concentrations of the reaction components were 1.0 M each primer, 2.5 M MgCl 2 , and 1ϫ SYBR Green master mix. The primers used and cycling conditions are listed in Table 1 . In order to compare expression levels of depleted and rescued embryos relative to controls, a dilution series of uninjected control cDNA was made and assayed in each LightCycler run. Undiluted control cDNA ϭ 100%, 1:1 cDNA: H 2 O ϭ 50% and 1:10 cDNA: H 2 O ϭ 10%. In experiments where multiple embryonic stages were examined, the dilution series was used from cDNA of the uninjected control stage of development predicted to give the highest expression of the gene product being amplified. These values were entered as concentration standards in the LightCycler sample input screen. Other controls included in each run were ϪRT and water blanks. These were negative in all cases but not included in the figures for lack of space.
After each elongation phase, the fluorescence of SYBR green (a dye that binds double-stranded DNA giving a fluorescent signal proportional to the DNA concentration) was measured at a temperature 1°C below the determined melting point for the PCR product being analyzed. This excluded primer-dimers, which melt at a lower temperature, from the measurement. The fluorescence level is thus quantitated in real-time, allowing the detection and display of the log-linear phase of amplification as it happens. LightCycler quantification software v1.2 was used to compare amplification in experimental samples during the log-linear phase to the standard curve from the dilution series of control cDNA. The comparisons are displayed as histograms. For each primer pair used, we optimized conditions so that melting curve analysis showed a single melting peak after amplification, indicating a specific product.
Western Blot Analysis
Protein extractions were carried out by the freon extraction method for total protein, to remove yolk from protein lysates (Heasman et al., 1994) or as described previously for membrane and supernatant fractions (Kofron et al., 1997) . Polyclonal ␤ catenin antibody 9428 was a gift from Dr. Pierre McCrea and was used at a dilution of 1:1000. The axin antibody was prepared by immunizing rabbits with a recombinant axin fragment encoding residues 328 -429 of Xenopus axin (Hedgepeth et al., 1999a) and was used at 1:1000 dilution. Western blots were stripped and reprobed for ␣-tubulin (Sigma clone DM 1A, 1:10,000) or hnRNP (1: 1000 dilution) as a loading control.
Whole-Mount Immunostaining and Confocal Analysis
Vitelline membranes were removed from control or depleted embryos at the midblastula stage. These embryos were fixed in 80 mM K Pipes, pH 6.8, 1 mM MgCl 2 , 5 mM EGTA, 0.2% Triton X-100 containing 3.7% formaldehyde for 3 h at room temperature. Fixed embryos were then blocked 12 h in 1ϫ PBS containing 10% horse serum and 4% BSA. Blocked embryos were incubated with ␤-catenin antibody (9428, 1:250) in TBSN (TBS ϩ 0.1% NP-40) for 24 h at room temperature. Embryos were washed three times for 8 h in TBSN at room temperature. The embryos were then incubated with a CY5-GARb secondary antibody (Jackson ImmunoResearch) for 24 h at room temperature and washed three times for 8 h in TBSN. Control embryos were treated identically except for incubation in primary antibody. After staining, embryos were dehydrated in MeOH and cleared in Murray's clear (1:2 benzyl alcohol:benzyl benzoate). Staining was visualized on a Zeiss LSM 510 confocal microscope using the 633-nm laser. Optical sections of 15 m were taken at 10-m intervals starting at the vegetal pole and ending at the animal pole. Images of the vegetal half of embryos were reconstructed in a single plane by using the Zeiss LSM software.
RESULTS
Antisense Oligonucleotides Deplete axin mRNA and Protein but Not the Related Xarp mRNA
Ten antisense oligos complimentary to maternal axin mRNA were tested for their ability to degrade the mRNA. A Northern blot of RNA from injected oocytes is shown in Fig. 1A . Two of the oligos depleted the mRNA to 6% (M5) and 2% (M7), respectively, of the wild-type level. Recently, a second maternal axin-like-related protein (Xarp) has been described that has 43% similarity to axin, and has been shown to be indistinguishable from axin in functional assays (Itoh et al., 2000) . Since the oligos 5 and 7 used in these experiments are also partially complementary to Xarp mRNA ( Fig. 1A; 14/18 nucleotides for oligo 7), we tested whether these oligos also degraded Xarp mRNA, by reprobing the Northern blot with a Xarp probe. The oligos had little activity in reducing maternal Xarp mRNA (oligo 5, 84% remained; oligo 7, 72% remained).
To study protein levels, we used a polyclonal antibody raised against a recombinant axin fragment to determine whether axin protein was localized in wild-type embryos. We established that axin protein is expressed at the same level in dissected dorsal and ventral halves of wild-type embryos at the 4-to 8-cell stage (Fig. 1B) . Next, we compared axin protein levels in membrane and supernatant fractions of a crude membrane preparation of wild-type and mat-axin Ϫ blastulae (Fig. 1C) . Axin protein was expressed more abundantly in the cytoplasmic fraction in wild-type embryos. In comparison, the amount of axin protein in mat-axin Ϫ embryos was reduced compared to control levels. The maternally encoded axin protein was reduced to 82% of wild-type levels in the soluble fraction and 54% of wildtype levels in the membrane associated fraction (Fig. 1C ). Westerns were repeated twice with whole embryo extracts. Injection of 3 ng of M7 oligo caused a reduction to 80% of wild-type levels, while injection of 4.5 ng of M7 oligo resulted in a 40% reduction in total protein levels at the midblastula stage (data not shown).
The Loss of Axin Results in the Stabilization of ␤ Catenin Protein and Its Ventral as Well as Dorsal Nuclear Localization
Previous studies have shown that overexpressed human axin causes down-regulation of endogenous ␤ catenin in human colon cancer cells (Hart et al., 1998) . Furthermore, the overexpression of axin mRNA causes a decrease in overexpressed HA-tagged ␤ catenin in Xenopus embryos (Fagotto et al., 1999) , and the addition of axin protein into Xenopus egg extracts increases the rate of ␤ catenin degradation (Salic et al., 2000) . Here, we tested the effect of endogenous axin depletion on the levels and distribution of endogenous ␤ catenin. Crude membrane and soluble fractions of wild-type and mat-axin Ϫ blastulae were compared for ␤ catenin protein levels (Fig. 1C) . In three experiments, the amount of ␤ catenin in the membrane-associated pool was 124, 124, and 120% of wild-type levels in mat-axin Ϫ embryos, while that in the soluble pool was increased to 112, 111, and 115% compared to wild-type levels.
Since ␤ catenin has been shown to be more concentrated in dorsal nuclei than in ventral nuclei in blastula-stage embryos (Schneider et al., 1996; Larabell et al., 1997) , we next tested whether this localization was altered in axindepleted embryos. Mat-axin Ϫ and control wild-type embryos were marked on their dorsal sides at the 4-cell stage with Nile Blue sulphate crystals, fixed at the midblastula stage, stained with a ␤ catenin-specific antibody as whole mounts, and visualized by confocal microscopy. The dorsal side was visible because of the auto-fluorescence of the Nile blue mark (arrow in Figs. 1D and 1E ). Plasma membraneassociated ␤ catenin was present equally on the dorsal and ventral sides of wild-type and mat-axin Ϫ embryos (arrowhead). As shown previously, dorsal nuclear staining was enhanced compared to ventral in wild-type embryos (Fig.  1D) (Schneider et al., 1996; Larabell et al., 1997) . In comparison, in mat-axin Ϫ embryos, nuclear ␤ catenin was equally concentrated in both dorsal and ventral nuclei (Fig.  1E ) (a total of 17/17 cases in two experiments).
Depletion of Maternal Axin Causes a Dorso/ Anteriorized Phenotype
We next investigated the effect of axin depletion on embryonic development. Embryos derived from oligoinjected oocytes (3-3.5 ng oligo M7) were fertilized 36 h after oligo injection. They developed normally until the gastrula stage. Blastopores formed 30 min later than in wild-type embryos and became more highly pigmented and deeper than controls. At higher doses (3.5-4 ng), the blastopores failed to close. During the neurula stage, embryos elongated more extensively than controls. This caused damage to the embryos as they pressed on their vitelline envelopes. Thus, embryos survived better and elongated more when the envelopes were removed and they were cultured in 0.5 M MMR on agar. By the tailbud stage, embryos had "dorsalized" characteristics, similar to lithium-treated embryos, including enlarged cement glands, enlarged heads, no tails, and elongated, abnormally positioned notochords ( Fig. 2A: 94/95 cases in 7 experiments) (Kao and Elinson 1998) . Embryos generally died during the late tailbud stage because of rupture and disaggregation of the vegetal area. At higher doses (4 -5 ng), the embryos died during the neurula stage due to leakage of cells from the open blastopores. Oligo M5 caused the same dorso-anteriorized phenotype at 4 -5 ng concentration (data not shown).
To show that the phenotype was specifically due to the loss of axin, we tested whether synthetic axin mRNA was able to rescue mat-axin Ϫ oocytes. Then, 3-4 ng oligo M7 was injected into oocytes, and the oocytes were cultured 36 h before axin mRNA was injected vegetally into half of them. The oocytes were then fertilized and scored for rescue at the tailbud stage. Table 2 shows data from two such experiments and Fig. 2B shows representative embryos. Reintroduction of axin mRNA caused significant phenotypic rescue, as measured by normal axis proportions, axis elongation, and reduction of head structures. The embryos were extremely sensitive to the dose of rescuing mRNA. A doubling of the rescuing dose caused a loss of head structures (11/12 cases) (Fig. 2B arrow) , showing that oligo depletion of the mRNA and its replacement with injected axin mRNA have opposite and titratable effects.
The Profile of Molecular Markers Expressed in Axin-Depleted Embryos
Although "dorsalized" embryos of the above appearance have been described as the result of lithium treatment, there has been no detailed study of the expression of molecular markers in such embryos. Here, we analyzed by real-time RT-PCR a staged series of wild-type, mat-axin Ϫ ,   FIG. 4 . Dorso-ventral differences in the expression of BMP4, Xwnt8, and chordin in axin-depleted gastrulae. Uninjected and mat-axin Ϫ embryos were bisected at the early gastrula stage and cultured to the midgastrula stage before freezing for RT-PCR. Each bar represents the expression of RNA prepared from four dorsal or ventral halves. The uninjected dorsal sample was used to generate the dilution series for the standard curve against which other samples were compared. In each case, ornithine decarboxylase (ODC) is used as a loading control (data not shown), and each bar is normalized to the level of ODC expression. UD ϭ uninjected, AD axin depleted dorsal; UV ϭ uninjected ventral; AV ϭ axin depleted ventral. and mat-axin Ϫ ϩ axin mRNA-injected embryos for the expression of zygotic genes characteristic of the organizer, (siamois, Xnr3, goosecoid, chordin; Fig. 3A) , of general and ventral mesoderm (Xbra, Xwnt8, BMP4, Xvent 1 and 2; Fig.  3B ), of neural and anterior ectodermal fates (Xnrp1, Xag1, Otx2, Krox 20; Fig. 3C ), and general endodermal (Xsox17, Mixer) and anterior endodermal fates (cerberus and Xhex; Fig. 3D ). The most significant changes characteristic of the mat-axin Ϫ state was the overexpression of organizer markers siamois, Xnr3, chordin, gsc (Fig. 3A) , and, less dramatically, Xnot1 and Xlim1 (data not shown). Surprisingly, the ventral mesodermal genes BMP4, Xvent1, and 2 were little affected in the mat-axin Ϫ embryos at the midgastrula stage, although Xvent 2 mRNA was less abundant than in the uninjected controls at the early gastrula stage (Fig. 3B) . The general mesodermal marker Xbra was reduced 50% compared to the control level at the midgastrula stage (Fig. 3B) . The only marker examined that was dramatically downregulated was the ventral and lateral mesodermal marker Xwnt8, which was reduced to 10% compared to control levels (Fig. 3B) . The anterior ectodermal markers Otx2 and Xag1 also showed significant overexpression compared to controls while the posterior neural marker Krox 20 was decreased (Fig. 3C) . The anterior endodermal gene Xhex was enhanced 2-to 3-fold above the control level. In contrast other endodermal genes, Xsox 1, Mixer, and Mix.2 were only slightly increased in mat-axin Ϫ embryos (Fig. 3D and data not shown). In summary, the effect of depletion of axin protein was to cause the overexpression of several organizer genes, and anterior genes of both ectodermal and endodermal germ layers, and to inhibit the expression of Xwnt8.
Zygotic Xwnt 8 but Not BMP4 Expression Is Negatively Regulated by the Maternal ␤ Catenin/ XTcf-3 Pathway in Both Dorsal and Ventral Halves of Midgastrula-Stage Embryos
Since axin-depleted embryos overexpress dorsal markers, and have reduced expression of the ventral marker Xwnt8 and little affected BMP4 expression, we examined whether these effects were localized to the dorsal or ventral side of embryos at the gastrula stage. To test this, uninjected and mat-axin Ϫ embryos were bisected into dorsal and ventral halves as soon as the dorsal lip of the blastopore appeared, using this as a guide to the dorsal side. The pieces were cultured on until sibling uninjected control embryos reached the midgastrula stage, since this was the time of peak expression of ventral markers (as shown in Fig. 3B ) and frozen for real-time RT-PCR. In two experiments, it was clear that chordin was overexpressed both dorsally and ventrally in axin-depleted embryos, Xwnt 8 was severely down-regulated, and BMP4 transcripts were slightly downregulated on the ventral side (Fig. 4) . In comparison with ventral uninjected halves, the ventral axin-depleted halves expressed 430 and 450% the wild-type level of chordin, 16 and 18% the level of Xwnt 8, and 92 and 67% the level of BMP4 mRNA. This shows that, at the midgastrula stage, the maternal Wnt pathway is not a major regulator of BMP-4 expression.
The Rescue of the Dorso-Anteriorized Phenotype Depends on the Site of Injection of axin mRNA
Next, we tested whether axin-depleted embryos could be rescued by axin mRNA injection after fertilization. The experiments described above show that axin is ubiquitously expressed in the wild-type blastula, and that a small reduction in axin protein causes both dorsal and ventral cells to contain nuclear ␤ catenin. One prediction would be that reintroduction of axin at any site would cause those cells to turn over ␤ catenin, repress dorsal markers, and thus rescue the wild-type appearance. This is suggested by overexpression experiments in wild-type embryos, where axin mRNA injected dorsally at the 4-cell stage causes phenotypic ventralization and reduction of dorsal markers (Zeng et al., 1997; Fagotto et al., 1999) .
To test this, we first titrated the effect of axin mRNA on wild-type embryos by injecting a dilution series into the dorsal side of embryos at the 4-cell stage (Fig. 5) . We found that surprisingly small amounts of mRNA (12 pg) caused significant phenotypic ventralization, i.e., loss of heads. Higher doses up to 300 pg had similar effects; 3 ng caused toxic nonspecific effects. We also tested the degree to which these doses increased axin protein levels at the blastula stage, and found that doses of 25 pg caused a greater than 10-fold increase in expression levels (Fig. 5F ).
Next, we compared the ability of axin mRNA injected before and after fertilization to rescue mat-axin Ϫ oocytes. axin mRNA (60 pg) was injected into axin-depleted oocytes in the vegetal pole, and the same dose was used in sibling oocytes after fertilization, targeting the mRNA either to the vegetal pole, or into the two dorsal or two ventral blastomeres at the 4-cell stage. To confirm that the site of injection was dorsal or ventral in wild-type embryos and to study the location and fate of the cells injected, ␤ galactosidase mRNA was coinjected with axin mRNA (Figs. 6A-6C ). Figure 6A shows that, in wild-type embryos, dorsal injection resulted in the incorporation of the marker in dorsal tissues, particularly the notochord, while ventral injection resulted in blue cells in the ventral and posterior regions and the hypochord. Figure 6D and Table 3 show the results of this experiment. As before, injections of axin mRNA vegetally into mat-axin Ϫ oocytes rescued the phenotype. The same dose injected into the ventral side of 4-cell-stage mat-axin Ϫ embryos also caused a significant degree of rescue. In contrast, Mat-axin Ϫ embryos injected with RNA on the dorsal side did not develop normal tail structures and retained enlarged cement glands, even though sibling wildtype embryos injected dorsally with 60 pg of mRNA were ventralized (data not shown). Vegetally injected embryos developed with a degree of rescue intermediate between dorsal and ventral injections (Fig. 6D) . ␤ galactosidase staining confirmed that, when axin mRNA was injected on the ventral side of mat-axin Ϫ embryos, the progeny of the injected cells were found in posterior and ventral endodermal sites, and were largely excluded from dorsal structures. In contrast, when axin mRNA was injected dorsally, blue cells were found in large clones in the abnormal dorsoanteriorized embryos (Fig. 6C) . The lack of phenotypic rescue in mat-axin Ϫ embryos injected dorsally with axin mRNA was confirmed in histological sections. Both axindepleted embryos and those injected with axin mRNA dorsally contained excessive notochord tissue and abnormal head structures (Fig. 7) .
The experiment was repeated using a lower dose of axin mRNA (3 pg) with the same result (Figs. 8A-8G) , and sibling embryos were frozen at the gastrula stage to examine the effects of injection on dorsal markers. Surprisingly, we found that the expression of the organizer genes siamois, Xnr3, goosecoid, and chordin were reduced toward wild-type levels in mat-axin Ϫ embryos in which axin mRNA was injected dorsally, even though they were not phenotypically rescued (Fig. 8H ). This dose of axin mRNA injected dorsally into wild-type embryos caused slight reduction in head structures (Fig. 8D) .
To confirm this result, and to further examine the localized effects of dorsal or ventral injection of axin mRNA in wild-type and mat-axin Ϫ embryos, we repeated the experiment, and dissected embryos into dorsal and ventral halves at the early gastrula stage, to examine the effects on dorsal and ventral markers in each half (Fig. 9) . Sibling embryos were allowed to develop to the tailbud stage (Fig. 9A) . Again, ventral but not dorsal injection of axin mRNA rescued the mat-axin Ϫ embryos. As shown in Fig. 9B , expression of dorsal genes chordin, siamois, Xnr3, and gsc was concentrated in the dorsal halves of wild-type embryos, while ventral genes BMP4 and Xwnt 8 were more abun- dantly expressed ventrally, as expected. In axin-depleted embryos, the dorsal markers were raised both dorsally and ventrally, with the exception of chordin, whose expression would be expected to peak at a slightly later point in gastrulation. In all cases where axin mRNA was injected, whether into wild-type or mat-axin Ϫ embryos, it caused a reduction in the expression of dorsal markers on the side in which it was injected. It also caused an increase in the level of expression of Xwnt 8, without significantly affecting BMP4 expression. This confirmed the finding described above that the Wnt pathway is not a major regulator of BMP4 expression in early gastrula-stage embryos. It also suggested that repression of dorsal gene expression alone is not sufficient to restore ventral fates in axin-depleted embryos.
To examine the possibility that a different dose of axin mRNA might rescue the phenotype dorsally, a range of doses was injected on the dorsal side. In five experiments (Table 4) , axin mRNA injections of doses ranging from 5 pg to 1.5 ng injected dorsally at the 4-cell stage did not rescue the phenotype, even though they caused a reduction of the expression of organizer genes siamois, chordin, Xnr3, and gsc (data not shown). Ventral injection of low doses of axin mRNA rescued in 50% of cases, but higher doses did not rescue (200 pg to 1.5 ng).
We conclude that ventral localization of axin activity is required for normal axial patterning. Dorsal expression of axin in axin-depleted embryos disrupts dorsal specification with regard to organizer markers but does not cause dorsal cells to adopt ventral fates.
DISCUSSION
Since maternal axin is only one component of many that may regulate ␤ catenin levels in early embryos, and a closely related axin-like protein (Xarp) has recently been identified, we asked here whether axin plays an essential role in axis patterning, by carrying out a loss of function analysis. Interestingly, although axin protein was only slightly reduced in total amount compared to control levels in early Xenopus embryos, there was a dramatic effect on development. In all cases, embryos treated with an antisense oligo complementary to axin developed with severe dorso-anteriorized phenotypes. This was specifically due to the loss of axin, since the phenotype was rescued by the injection of axin mRNA. This result is reminiscent of loss-of-function experiments targeting maternal ␤ catenin, where relatively small depletions in protein caused extreme ventralized phenotypes (Heasman et al., 1994; Kofron et al., 1997) . A likely explanation for this is that, as for ␤ catenin, most cellular axin is stable and not involved in the Wnt signaling cascade. Perhaps only newly synthesized axin protein regulates the soluble ␤ catenin levels involved in signaling.
The related protein Xarp, is also a maternal component with similar properties to axin (Itoh et al., 2000) . Embryos depleted of axin were not significantly depleted of Xarp mRNA, and yet were dorso/anteriorized. This suggests that Xarp is unable to substitute for axin. 
The Dorso/Anterior Phenotype
The earliest effects of axin depletion are seen at the blastula stage when nuclear ␤ catenin is evident in both ventral and dorsal nuclei. At the gastrula stage, the formation of the blastopore is delayed, but gastrulation movements are then enhanced. This phenotype correlates with the overexpression of organizer genes in axin depleted embryos at this time. We show here that axin depletion results in both an increase in the expression of dorsal genes in dorsal cells at the gastrula stage as well as the activation of their expression in ventral nuclei to the wild-type dorsal level (Fig. 4 and data not shown) . How does this activity result in the observed phenotype? At least three mechanisms may be at work. First, the expression of inhibitors of BMP signaling such as chordin and cerberus now occurs across the whole embryo and may prevent Smad1 phosphorylation and thus inhibit ventral-specific gene transcription. Second, the expression of transcription factors involved in head specification such as Xhex and Xlim is enhanced in axin-depleted embryos. Third, some aspects of the phenotype, including enlarged cement glands and excessive notochord formation, may be due to the lack of zygotic Xwnt 8 expression in axin depleted embryos (Figs. 3B and 4) . In situ studies have shown that Xwnt 8 is normally expressed in lateral and ventral equatorial cells during the gastrula stage (Christian et al., 1991) , and we find here that its expression is severely reduced both dorsally and ventrally in mat-axin Ϫ embryos. When zygotic Wnt signaling was blocked on the ventral side by using a fragment of Xenopus frizzled 8, ECD8, this inhibitory fragment caused the formation of secondary axes including notochord and head structures (Itoh and Sokol, 1999) . Thus part of the dorso-anterior phenotype of axin-depleted embryos may result from inhibiting zygotic Xwnt 8 expression, preventing it inducing or maintaining ventral fates.
The Expression of Xwnt 8 Is Negatively Regulated by the Maternal Wnt Pathway but BMP4 Expression Is Not
Our study reveals that there are at least two types of ventral gene regulation (Fig. 10) . Xwnt8 is an example of a ventral molecular marker that fits into the simple switch model of dorsal versus ventral fate specification. It is down-regulated in mat-axin Ϫ embryos where we have shown that nuclear ␤ catenin is ubiquitous, and is conversely up-regulated in ␤ catenin-depleted embryos, where dorsal signals are lost (Heasman et al., 1994) . If all ventral markers were regulated like Xwnt 8, it would indicate that the Wnt pathway was the master regulator of both dorsal and ventral fates. However, this form of regulation is not the case for all ventral early zygotic genes. In this study, we found that the expression of zygotic molecular markers of ventral fates, BMP 4, Xvent 1, and 2, was not significantly regulated by the Xwnt pathway at the gastrula stage. Other studies suggest that the reverse is also true-the extent of dorsal gene expression is not influenced by ventrally localized signals. In zebrafish, the dorsal gene chordin is not changed in its expression in bmp2/swr mutants (MillerBertoglio et al., 1997) and gsc is also not expanded in its expression in swr mutants (Mullins et al., 1996) . The early independence of ventral and dorsal signaling pathways in Xenopus was also indicated by studies in which loss of BMP signaling did not induce gsc on the ventral side (Steinbeisser et al., 1995) , and in which ectopic BMP signaling was unable to affect the expression of the siamois homolog, Xtwn in the organizer (Laurent and Cho, 1999) .
Ventral Specification Involves Both Suppression of the Dorsal Signaling Pathway by Axin and Independent Activation of Ventral Signaling Pathways
The most unexpected finding of this study was that, although dorsal, ventral, or vegetal injections of 3-30 pg quantities of axin mRNA reduced organizer markers in axin-depleted embryos, this did not translate into the rescue of the wild-type phenotype, unless injections were made on the ventral side. Why does dorsal injection of axin mRNA not rescue an axin-depleted embryo, when it does ventralize a wild-type embryo? Several possibilities could account for this.
One possibility that was tested exhaustively here was that the rescuing ability of axin was simply very dosesensitive. It was certainly true that, on the ventral side, doses of 3-100 pg axin mRNA rescued the phenotype, but higher doses did not. We found that doses of only 12 pg of mRNA were required to produce protein levels above wildtype amounts, and 100 pg caused a vast overexpression of protein. Similarly, in egg extracts, high concentrations of axin protein were found to block ␤ catenin degradation, while lower doses enhanced it (Salic et al., 2000) . This suggests that there are other components of the degradation complex that become limiting at high concentrations of axin. Certainly, over a range of 3 pg to 1.5 ng injected on the dorsal side, no dose of axin mRNA rescued the phenotype.
A second possibility for the lack of rescue on the dorsal side is that another localized component of the Wnt pathway, such as dishevelled, continues to prevent ␤ catenin degradation on the dorsal side, regardless of the presence of injected axin protein. Another limiting component may be GSK3, which is required for axin's activity (Salic et al., 2000) and may not be present on the dorsal side (Dominguez and Green, 2000) . These explanations seem unlikely to be correct, since the expression of organizer genes is clearly reduced by the injection of axin mRNA on the dorsal side of axin-depleted embryos, suggesting that axin is able to reduce ␤ catenin/Xtcf3-initiated transcription here, whether or not dishevelled or GSK3 are involved. An alternative explanation could be that there may be a second, Wnt-independent dorsal pathway that dominates even in the presence of excess axin. However, if this were the case, it would be expected also to dominate in wild-type embryos and prevent their ventralization.
Another possibility could be that the rescue of ventral structures on the dorsal side by the injection of axin mRNA is prevented by the presence of other dorsally localized signaling pathways which the injected mRNA blocks. For example, previous experiments showed that blocking Wnt signaling in animal cells at the 32-cell stage using a morpholino oligo directed against ␤ catenin causes an increase in cement gland formation and abnormal head development, which does not occur when vegetal cells are injected (Heasman et al., 2000) . It is possible that injection of rescuing doses of axin mRNA may have the same effect as the morpholino oligo against 
FIG. 9.
Dorsally injected axin mRNA restores normal expression of dorsal markers in axin-depleted embryos but does not rescue the dorsalized phenotype. Uninjected, uninjected ϩ 60 pg axin mRNA (dorsal or ventral at 4-cell stage), mat-axin Ϫ , and mat-axin Ϫ ϩ 60 pg axin mRNA (dorsal or ventral at 4-cell stage) embryos at the tailbud stage (A). Embryos were bisected at the early gastrula stage and cultured to the midgastrula stage before freezing for RT-PCR, shown schematically in (B). Real-time PCR was then used to analyze relative gene expression of selected dorsal or ventral markers in the dorsal or ventral halves of the embryos. Each bar represents the expression of RNA prepared from four dorsal or ventral halves. The uninjected dorsal sample was used to generate the dilution series for the standard curve against which other samples were compared. In each case, ornithine decarboxylase (ODC) is used as a loading control (data not shown), and each bar is normalized to the level of ODC expression. UD ϭ uninjected, AD axin depleted dorsal; UV ϭ uninjected ventral; AV ϭ axin depleted ventral. The location of the mRNA rescue is indicated along the bottom of the figure. ␤ catenin, reducing ␤ catenin levels and blocking a later Wnt pathway involved in head formation. However, this is unlikely to account for the lack of rescue with low doses of axin mRNA, since the doses used do not cause the ␤ catenin morpholino phenotype of enlarged cement glands in wild-type embryos.
A final possible explanation of the failure of rescue experiments may be that the wild-type phenotype depends both on localized ventral determinants and on correct suppression of organizer genes on the ventral side. We have shown here that, independently of the Wnt pathway, some ventral determinants are expressed and more enriched on the ventral side. In this model, the wild-type embryo is ventralized when axin is injected dorsally, because it suppresses dorsal-specific genes dorsally, while the ventral side continues its normal fate, to become ventral. In axindepleted embryos, when axin mRNA is injected dorsally, it again suppresses dorsal gene expression. However, this side lacks sufficient ventral determinants to specify ventral fates. The ventral side of the embryo is where BMPs are enriched, but this still has ectopic expression of the dorsal genes, which dominate and maintain the dorsal phenotype. Further studies are needed to distinguish between these possiblities and to identify the endogenous factors regulating localized zygotic BMP4 and Xvent expression.
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FIG. 10.
Different modes of regulation of ventral genes are likely to operate after MBT. This and other work suggest that ventral fate specification requires both the repression of dorso/anterior gene expression (shown in A; simple switch model) and the localized activation of some genes (shown in B). In model A, ventral zygotic genes are expressed throughout the equatorial zone and are subsequently repressed dorsally. Xwnt8 is an example of a ventral molecular marker that fits into the category of genes with type A regulation. It is expressed ventrally and laterally in the marginal zones of wild-type early gastrulae, but is down-regulated in mat-axin Ϫ embryos. In model B, ventral zygotic genes are not activated in the organizer, and are initiated by localized maternal determinants, and are not modulated by the maternal wnt pathway. Zygotic BMP4, Xvent1, and 2 may be examples of type B regulation since their expression is little affected in mat-axin Ϫ embryos.
